Pharmaceuticals

United States Methylphenidate Market Report 2017

  • QYR904432
  • 115 Pages
  • February 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Methylphenidate

Revenue, means the sales value of Methylphenidate

This report studies sales (consumption) of Methylphenidate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Pfizer

Teva

Novartis

Sandoz

GSK

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Split by applications, this report focuses on sales, market share and growth rate of Methylphenidate in each application, can be divided into

Application 1

Application 2

Table of Contents

United States Methylphenidate Market Report 2017

1 Methylphenidate Overview

1.1 Product Overview and Scope of Methylphenidate

1.2 Classification of Methylphenidate

1.2.1 Type I

1.2.2 Type II

1.3 Application of Methylphenidate

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Methylphenidate (2012-2022)

1.4.1 United States Methylphenidate Sales and Growth Rate (2012-2022)

1.4.2 United States Methylphenidate Revenue and Growth Rate (2012-2022)

2 United States Methylphenidate Competition by Manufacturers

2.1 United States Methylphenidate Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Methylphenidate Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Methylphenidate Average Price by Manufactures (2015 and 2016)

2.4 Methylphenidate Market Competitive Situation and Trends

2.4.1 Methylphenidate Market Concentration Rate

2.4.2 Methylphenidate Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Methylphenidate Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Methylphenidate Sales and Market Share by States (2012-2017)

3.2 United States Methylphenidate Revenue and Market Share by States (2012-2017)

3.3 United States Methylphenidate Price by States (2012-2017)

4 United States Methylphenidate Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Methylphenidate Sales and Market Share by Type (2012-2017)

4.2 United States Methylphenidate Revenue and Market Share by Type (2012-2017)

4.3 United States Methylphenidate Price by Type (2012-2017)

4.4 United States Methylphenidate Sales Growth Rate by Type (2012-2017)

5 United States Methylphenidate Sales (Volume) by Application (2012-2017)

5.1 United States Methylphenidate Sales and Market Share by Application (2012-2017)

5.2 United States Methylphenidate Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Methylphenidate Manufacturers Profiles/Analysis

6.1 Pfizer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Methylphenidate Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Pfizer Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Teva

6.2.2 Methylphenidate Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Teva Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Novartis

6.3.2 Methylphenidate Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Novartis Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Sandoz

6.4.2 Methylphenidate Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Sandoz Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 GSK

6.5.2 Methylphenidate Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 GSK Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

7 Methylphenidate Manufacturing Cost Analysis

7.1 Methylphenidate Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Methylphenidate

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Methylphenidate Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Methylphenidate Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Methylphenidate Market Forecast (2017-2022)

11.1 United States Methylphenidate Sales, Revenue Forecast (2017-2022)

11.2 United States Methylphenidate Sales Forecast by Type (2017-2022)

11.3 United States Methylphenidate Sales Forecast by Application (2017-2022)

11.4 Methylphenidate Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Methylphenidate

Table Classification of Methylphenidate

Figure United States Sales Market Share of Methylphenidate by Type in 2015

Table Application of Methylphenidate

Figure United States Sales Market Share of Methylphenidate by Application in 2015

Figure United States Methylphenidate Sales and Growth Rate (2012-2022)

Figure United States Methylphenidate Revenue and Growth Rate (2012-2022)

Table United States Methylphenidate Sales of Key Manufacturers (2015 and 2016)

Table United States Methylphenidate Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Methylphenidate Sales Share by Manufacturers

Figure 2016 Methylphenidate Sales Share by Manufacturers

Table United States Methylphenidate Revenue by Manufacturers (2015 and 2016)

Table United States Methylphenidate Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Methylphenidate Revenue Share by Manufacturers

Table 2016 United States Methylphenidate Revenue Share by Manufacturers

Table United States Market Methylphenidate Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Methylphenidate Average Price of Key Manufacturers in 2015

Figure Methylphenidate Market Share of Top 3 Manufacturers

Figure Methylphenidate Market Share of Top 5 Manufacturers

Table United States Methylphenidate Sales by States (2012-2017)

Table United States Methylphenidate Sales Share by States (2012-2017)

Figure United States Methylphenidate Sales Market Share by States in 2015

Table United States Methylphenidate Revenue and Market Share by States (2012-2017)

Table United States Methylphenidate Revenue Share by States (2012-2017)

Figure Revenue Market Share of Methylphenidate by States (2012-2017)

Table United States Methylphenidate Price by States (2012-2017)

Table United States Methylphenidate Sales by Type (2012-2017)

Table United States Methylphenidate Sales Share by Type (2012-2017)

Figure United States Methylphenidate Sales Market Share by Type in 2015

Table United States Methylphenidate Revenue and Market Share by Type (2012-2017)

Table United States Methylphenidate Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Methylphenidate by Type (2012-2017)

Table United States Methylphenidate Price by Type (2012-2017)

Figure United States Methylphenidate Sales Growth Rate by Type (2012-2017)

Table United States Methylphenidate Sales by Application (2012-2017)

Table United States Methylphenidate Sales Market Share by Application (2012-2017)

Figure United States Methylphenidate Sales Market Share by Application in 2015

Table United States Methylphenidate Sales Growth Rate by Application (2012-2017)

Figure United States Methylphenidate Sales Growth Rate by Application (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer Methylphenidate Sales Market Share (2012-2017)

Table Teva Basic Information List

Table Teva Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

Table Teva Methylphenidate Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Methylphenidate Sales Market Share (2012-2017)

Table Sandoz Basic Information List

Table Sandoz Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

Table Sandoz Methylphenidate Sales Market Share (2012-2017)

Table GSK Basic Information List

Table GSK Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)

Table GSK Methylphenidate Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Methylphenidate

Figure Manufacturing Process Analysis of Methylphenidate

Figure Methylphenidate Industrial Chain Analysis

Table Raw Materials Sources of Methylphenidate Major Manufacturers in 2015

Table Major Buyers of Methylphenidate

Table Distributors/Traders List

Figure United States Methylphenidate Production and Growth Rate Forecast (2017-2022)

Figure United States Methylphenidate Revenue and Growth Rate Forecast (2017-2022)

Table United States Methylphenidate Production Forecast by Type (2017-2022)

Table United States Methylphenidate Consumption Forecast by Application (2017-2022)

Table United States Methylphenidate Sales Forecast by States (2017-2022)

Table United States Methylphenidate Sales Share Forecast by States (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370